Holen Sie sich die Stockscreener-App
6.1216
3.01%
0.1516
Schlusskurs vom Vortag:
$5.97
Offen:
$5.97
24-Stunden-Volumen:
27,159
Relative Volume:
0.16
Marktkapitalisierung:
$63.45M
Einnahmen:
$442.00K
Nettoeinkommen (Verlust:
$-30.46M
KGV:
-1.3726
EPS:
-4.46
Netto-Cashflow:
$-27.47M
1W Leistung:
+6.58%
1M Leistung:
-1.29%
6M Leistung:
+60.57%
1J Leistung:
+16.48%
1-Tages-Spanne:
$5.90
$6.1899
1-Wochen-Bereich:
$5.71
$6.56
52-Wochen-Spanne:
$2.2801
$13.50
Clene Inc Stock (CLNN) Company Profile
Firmenname
Clene Inc
Sektor
Branche
Telefon
801-676-9695
Adresse
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Vergleichen Sie CLNN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
6.14 | 61.69M | 442.00K | -30.46M | -27.47M | -4.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.37 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.29 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.64 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
814.78 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.34 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-10-04 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-07-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-09-28 | Eingeleitet | Oppenheimer | Outperform |
Clene Inc Aktie (CLNN) Neueste Nachrichten
D. Boral Capital Maintains 'Buy' Rating for CLNN with $23 Target - GuruFocus
Clene secures $28 million in registered direct offering for ALS drug - Investing.com India
Clene announces registered direct offering of over $28 million - MarketScreener
Clene Inc. Announces Oversubscribed Registered Direct Offering Exceeding $28 Million to Fund ALS Treatment Development - Quiver Quantitative
Clene Announces Registered Direct Offering of Over $28 Million - MarketScreener
Can Clene Inc. Equity Warrant stock weather global recessionEarnings Recap Report & Growth-Oriented Investment Plans - ulpravda.ru
Will Clene Inc. Equity Warrant stock reach Wall Street targetsJobs Report & Free Long-Term Investment Growth Plans - ulpravda.ru
Chipmakers Recap: Is Clene Inc. (84C0) stock a top hedge fund pickMarket Weekly Review & Long Hold Capital Preservation Plans - ulpravda.ru
How Clene Inc. Equity Warrant stock reacts to Fed rate cutsJuly 2025 Drop Watch & Daily Price Action Insights - ulpravda.ru
Why Clene Inc. Equity Warrant stock remains on buy listsEarnings Trend Report & Fast Exit and Entry Strategy Plans - ulpravda.ru
Will Clene Inc. stock gain from strong economyStop Loss & AI Based Buy/Sell Signal Reports - ulpravda.ru
Top Nanotechnology Stocks To Follow TodayJanuary 8th - MarketBeat
Why Clene Inc. (84C0) stock stays undervalued2025 Buyback Activity & Reliable Entry Point Trade Alerts - ulpravda.ru
How Clene Inc. stock reacts to Fed rate cutsPortfolio Gains Report & Risk Controlled Swing Alerts - ulpravda.ru
Published on: 2026-01-08 21:03:18 - ulpravda.ru
Is Clene Inc. Equity Warrant stock a buy before product launchesGold Moves & Free Community Supported Trade Ideas - ulpravda.ru
Clene Inc. ten percent owner Ugwumba sells $78k in shares - Investing.com
Market Outlook: Will Clene Inc Equity Warrant stock continue dividend increasesJuly 2025 PostEarnings & Entry Point Strategy Guides - moha.gov.vn
Clene to Present at the Emerging Growth Conference - Investing News Network
Best Nanotechnology Stocks To Follow TodayJanuary 5th - MarketBeat
Top Nanotechnology Stocks To Add to Your WatchlistJanuary 4th - MarketBeat
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 13,095 Shares of Stock - MarketBeat
Chidozie Ugwumba Sells 4,015 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Published on: 2026-01-01 16:53:08 - moha.gov.vn
Nanotechnology Stocks To Follow TodayDecember 29th - MarketBeat
Nanotechnology Stocks To ResearchDecember 31st - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 8,096 Shares - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 4,138 Shares - MarketBeat
Ugwumba Chidozie sells Clene Inc. (CLNN) stock worth $73,123 By Investing.com - Investing.com Nigeria
Ugwumba Chidozie sells Clene Inc. (CLNN) stock worth $73,123 - Investing.com
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 6,831 Shares of Stock - MarketBeat
Clene Inc: Ugwumba sells $73k in CLNN stock By Investing.com - Investing.com South Africa
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 3,350 Shares - MarketBeat
Clene Inc: Ugwumba sells $73k in CLNN stock - Investing.com
Promising Nanotechnology Stocks To Follow TodayDecember 19th - MarketBeat
Short Interest in Clene Inc. (NASDAQ:CLNN) Increases By 47.4% - MarketBeat
Clene Inc. (NASDAQ:CLNN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Promising Nanotechnology Stocks To Follow NowDecember 22nd - MarketBeat
Promising Nanotechnology Stocks To Keep An Eye OnDecember 25th - MarketBeat
Nanotechnology Stocks To Keep An Eye OnDecember 23rd - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 4,367 Shares of Stock - MarketBeat
Chidozie Ugwumba Sells 5,582 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Promising Nanotechnology Stocks To ResearchDecember 8th - MarketBeat
Have Insiders Sold Clene Shares Recently? - simplywall.st
This Insider Has Just Sold Shares In Clene - 富途牛牛
Will Clene Inc. Equity Warrant stock beat EPS estimatesWeekly Profit Summary & High Accuracy Investment Signals - Улправда
Is Clene Inc. Equity Warrant stock attractive for retirement portfoliosWeekly Profit Report & AI Driven Stock Price Forecasts - Улправда
Why Clene Inc. stock remains on buy lists2025 Retail Activity & Stock Portfolio Risk Management - Улправда
Published on: 2025-12-19 17:52:46 - Bölüm Sonu Canavarı
Finanzdaten der Clene Inc-Aktie (CLNN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Clene Inc-Aktie (CLNN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ugwumba Chidozie | 10% Owner |
Jan 07 '26 |
Sale |
6.29 |
3,938 |
24,770 |
753,562 |
| Ugwumba Chidozie | 10% Owner |
Jan 06 '26 |
Sale |
6.04 |
3,111 |
18,790 |
757,500 |
| Ugwumba Chidozie | 10% Owner |
Dec 31 '25 |
Sale |
5.81 |
13,095 |
76,082 |
770,495 |
| Ugwumba Chidozie | 10% Owner |
Jan 02 '26 |
Sale |
5.73 |
4,015 |
23,006 |
766,480 |
| Ugwumba Chidozie | 10% Owner |
Dec 29 '25 |
Sale |
5.95 |
8,096 |
48,171 |
787,728 |
| Ugwumba Chidozie | 10% Owner |
Dec 30 '25 |
Sale |
6.03 |
4,138 |
24,952 |
783,590 |
| Ugwumba Chidozie | 10% Owner |
Dec 23 '25 |
Sale |
6.27 |
6,831 |
42,830 |
800,664 |
| Ugwumba Chidozie | 10% Owner |
Dec 26 '25 |
Sale |
6.32 |
3,350 |
21,172 |
795,824 |
| Ugwumba Chidozie | 10% Owner |
Dec 24 '25 |
Sale |
6.27 |
1,490 |
9,342 |
799,174 |
| Ugwumba Chidozie | 10% Owner |
Dec 19 '25 |
Sale |
6.45 |
5,582 |
36,004 |
387,568 |
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):